Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...

Culver City, California Saturday, March 1, 2025, 17:00 Hrs [IST] ...

Shardul Nautiyal, Hyderabad Saturday, March 1, 2025, 08:00 Hrs [IST] ...

US FDA approves first human milk-based fortifier for infants to support growth and recovery following surgery for gastroschisis: Duarte, California Saturday, March 1, 2025, 16:00 ...

MYndspan & MEGIN partner to make magnetoencephalography brain scans more accessible: London Saturday, March 1, 2025, 15:00 Hrs [IST] MYndspan, a pioneer in consumer brain health t ...

Third meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024 – Temporary recommendations ...

Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...

Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.

Planegg, Martinsried Saturday, March 1, 2025, 11:00 Hrs [IST] ...

McKinsey report says Indian pharma rose to global prominence led by export boom & improved compliance: Shardul Nautiyal, Mumbai Saturday, March 1, 2025, 08:00 Hrs [IST] McKinsey & ...

Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

Daiichi Sankyo announces establishment of upper limits for acquisition of own shares: Tokyo, Japan Saturday, March 1, 2025, 10:00 Hrs [IST] Daiichi Sankyo Company, Limited (hereaf ...